HIF1A and neoplasm: Cinobufagin suppresses tumor neovascularization by altering the endothelial mTOR/HIF-1α pathway to trigger vascular endothelial cell apoptosis mediated by ROS, and it is emerging as a promising natural anti angiogenic agent [62].